TRT vs. testosterone abuse: is the distinction as clean as claimed?

What did @ali_on_t actually say?

The creator's core argument is simple: testosterone itself is not dangerous, but high doses are. Specifically, they flagged that large amounts can make "your blood thicker" and may cause "problems with kidneys and water retention." That's the whole claim. No dosing numbers, no protocols, just a broad split between therapeutic use and abuse.

To be fair, this is a more measured take than most TRT content on TikTok. They're not selling a stack or promising body transformation. But the simplicity of the claim papers over some genuinely complicated cardiovascular and endocrine science that deserves more than a 20-second thumbnail.

Does the science back this up?

Partly, yes. The blood-thickening concern is real and reasonably well-documented. High-dose testosterone raises hematocrit, the percentage of red blood cells in your blood, which increases clotting risk. But the evidence is messier than "low dose good, high dose bad."

A 2023 randomized trial published in the New England Journal of Medicine (Lincoff et al., TRAVERSE trial) found that testosterone replacement therapy in middle-aged and older men with hypogonadism did not significantly increase major cardiovascular events compared to placebo, but it did increase rates of pulmonary embolism and atrial fibrillation. That's not nothing. Even at therapeutic doses, there are real cardiovascular signals that require monitoring. The kidney claim is less supported by robust trial data. Acute kidney injury has been reported anecdotally and in case reports tied to high-dose use and associated rhabdomyolysis, but it's not a primary mechanism of testosterone toxicity at any dose range.

What did they get wrong (or right)?

They got the hematocrit point roughly right, but oversimplified it. Saying high doses "can increase how thick your blood is" is accurate directionally. Testosterone stimulates erythropoiesis through EPO pathways, and supraphysiologic doses push hematocrit into dangerous territory. Saad et al. (2017, Andrology) documented elevated hematocrit as one of the most consistent adverse effects across testosterone studies.

Where they went wrong: framing therapeutic TRT as essentially risk-free. The TRAVERSE trial data shows that even clinically supervised, guideline-dosed TRT carries some risk. The creator implies a clean binary, abuse equals danger, TRT equals safe. That binary is convenient but not accurate.

• The kidney claim is weakly supported. Most renal complications tied to testosterone appear in the context of extreme bodybuilding doses combined with other agents, not testosterone alone.
• No mention of polycythemia as a named condition, which would have been more precise than "thick blood."
• No mention of lipid changes, suppression of natural testosterone production, or fertility effects, all documented even at replacement doses.

What should you actually know?

The dose-dependent framing has some truth to it, but the line between "therapeutic" and "abuse" isn't as clean as this video implies. Clinically supervised TRT typically targets testosterone levels within a normal physiologic range, and even then requires regular monitoring of hematocrit, PSA, lipids, and blood pressure.

If you are using testosterone outside of a supervised clinical setting, you don't have those guardrails. The cardiovascular risks at supraphysiologic doses are well-established. Baggish et al. (2017, Circulation) found significantly impaired left ventricular function in long-term anabolic steroid users compared to non-users and natural athletes. That's not water retention. That's structural heart damage.

Water retention itself is also more than a cosmetic issue at high doses. Sodium and water retention driven by testosterone's androgenic activity can raise blood pressure meaningfully, which compounds cardiovascular risk. The creator mentioned it in passing, but it deserves more weight than it got here.